The INK4a/ARF locus encodes two distinct tumour suppressors, p16
Introduction
The INK4a/ARF locus on human chromosome region 9p21 encodes two distinct proteins, which are translated in dierent reading frames from alternatively spliced transcripts (Quelle et al., 1995) . The a transcript, comprising exons 1a, 2 and 3, encodes the p16
INK4a cyclin dependent kinase inhibitor, while the smaller b transcript (exons 1b, 2 and 3) speci®es the alternative product, p14ARF (Quelle et al., 1995) . These INK4a/ARF encoded proteins play a central role in maintaining cell cycle control; p16
INK4a regulates G 1 -phase exit by inhibiting the phosphorylation of the retinoblastoma protein (pRb) (Serrano et al., 1993) and p14ARF acts via p53 to induce cell cycle arrest Kamijo et al., 1998) in response to hyperproliferative oncogenic signals de Stanchina et al., 1998; Palmero et al., 1998; . Consequently, mice lacking p16
INK4a and p19ARF (the mouse homologue of p14ARF) (Serrano et al., 1996) or p19ARF alone (Kamijo et al., 1997) are highly susceptible to tumourigenesis. Indeed, the INK4a/ARF locus is frequently deleted in human tumours, particularly in melanomas and pancreatic adenocarcinomas (Sharpless and DePinho, 1999) .
The INK4a/ARF locus is also mutated in the germline of 20 ± 40% of multiple case melanoma families . The p16
INK4a tumour suppressor is clearly important in melanoma predisposition; almost one third of melanoma-associated germline mutations aect the p16
INK4a speci®c exon 1a (FitzGerald et al., 1996; Harland et al., 1997; Holland et al., 1999; Hussussian et al., 1994; Kamb et al., 1994; Platz et al., 1997; Walker et al., 1995) and impair p16
INK4a function (Parry and Peters, 1996; Ranade et al., 1995; Reymond and Brent, 1995) . The role of p14ARF in melanoma susceptibility is not as clear. No germline mutations aecting the p14ARF speci®c exon1b have been identi®ed (FitzGerald et al., 1996; Platz et al., 1997 ) and yet many INK4a/ARF exon 2 mutations alter both the p16
INK4a and p14ARF amino acid sequence (Holland et al., 1999) . To determine the eect of such mutations on p14ARF function the functional domains of this protein must be de®ned. At present no information regarding the hdm2 binding sites on p14ARF are known and a single nucleolar localisation domain in the C-terminal half of the human ARF protein was recently mapped by deletion analysis (Zhang and Xiong, 1999 ) (see Table 1 ).
p14ARF activates p53-dependent pathways by inhibiting the p53 antagonist, hdm2 Pomerantz et al., 1998; Stott et al., 1998; Zhang et al., 1998) . Hdm2, a p53-inducible gene product, restricts p53-dependent transcription (Momand et al., 1992) , targets p53 for degradation by catalyzing the ligation of ubiquitin residues to p53 (Fuchs et al., 1998; Honda et al., 1997) and transports p53 to the cytoplasm for degradation by the proteasome (Roth et al., 1998; Tao and Levine, 1999) . The binding of ARF to hdm2 stabilizes p53 Pomerantz et al., 1998; Stott et al., 1998; Zhang et al., 1998) by inhibiting the in vitro ubiquitin ligation of p53 by mdm2 (the mouse homologue of hdm2) (Honda and Yasuda, 1999) and preventing the nuclear export of p53 and hdm2 (Zhang and Xiong, 1999) . The Nterminal region of the human and mouse ARF proteins is necessary and sucient for this function, whilst the C-terminal region is not required Zhang et al., 1998) . Murine p19ARF is a nucleolar protein that was found to sequester mdm2 in the nucleolus, thereby preventing p53-mdm2 interaction and leading to the activation of p53 in the nucleoplasm (Weber et al., 1999) .
A single N-terminal domain of basic amino acids ( C-terminus of the human ARF (
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) was recently shown to be involved in the nucleolar import of this protein (Zhang and Xiong, 1999) (Table 1) . This report identi®es a second arginine-rich domain in the human ARF protein (   1   MVRRFLVTLRIRR   13 ) that is required for correct nucleolar localization (Table 1) . This domain, which is located in the N-terminus of p14ARF, is dierent from the mouse N-terminal nucleolar localization domain identi®ed by Weber et al. (1999) but is conserved in mouse and Monodelphis ARF proteins. The N-terminal p14ARF nucleolar localization domain identi®ed in this work is also important for p14ARF-hdm2 binding and the cell cycle inhibitory action of p14ARF.
Results
p14ARF exon 1b and exon 2 both encode sequences sufficient for nucleolar localization
To initially evaluate the subcellular distribution of the human ARF protein, full-length p14ARF (residues 1 ± 132), the amino-terminal half of p14ARF (residues 1 ± 64; referred to here as p14ARF 1 ± 64 ) and the p14ARF carboxy terminus (residues 65 ± 132; referred to here as p14ARF 65 ± 132 ) were each cloned in frame with the FLAG-epitope in the pFLAG-CMV-5b vector. Transfected p14ARF-FLAG was found to localize predominantly in the nucleoli of most transfected NM39 melanoma cells and Saos-2 cells at 40 h post transfection. The localization of p14ARF 1 ± 64 and p14ARF 65 ± 132 in transiently transfected NM39 and Saos-2 cells indicated that neither domain was sucient for exclusively nucleolar targeting and that both fragments were found throughout the cell (Figures 1 and 2 ). Each domain therefore contains sequences sucient to achieve import into the nucleus and to reach the nucleolus, but lack sequences or sucient conformational stability to be retained there exclusively. NM39 cells showed greater selectivity than Saos-2 cells in tracking the p14ARF 1 ± 64 N-terminal domain. p14ARF 1 ± 64 reached the NM39 nucleus in approximately half the cells and a small proportion exhibited exclusive nucleolar localisation ( Figure 2 ).
As expected, the expression of wild-type p14ARF-FLAG induced G 1 cell cycle arrest in the NM39 cell line, which expresses p53 (Figure 1 ). Transient expression of p14ARF 1 ± 64 -FLAG con®rmed that the exon 1b-encoded domain was sucient to induce G 1 cell cycle arrest in NM39 cells, with a potency similar to the full-length p14ARF-FLAG construct (Figure 1 ). In contrast, ectopic expression of p14ARF 65 ± 132 -FLAG was unable to arrest the cell cycle (Figure 1 ).
Identification of a novel amino-terminal p14ARF nucleolar localization domain
To identify p14ARF nucleolar localization domains, a series of FLAG-tagged constructs was engineered and assayed for subcellular distribution and cell cycle eects. Proteins targeted to the nucleolus often contain highly basic domains required for nuclear import and RNA binding. Indeed, the critical nucleolar import domain in murine p19ARF includes a cluster of 12 amino acids with four arginine residues (see Introduction; Weber et al. (1999) ) (this arginine rich region is not conserved in human ARF). A dierent N-terminal, basic 13 amino acid domain (residues 1 ± 13), with ®ve arginine residues showed conservation in the mouse, human and Monodelphis ARF proteins (Figure 2 , Table 1 ). We tested the functionality of this sequence by deleting it from p14ARF. The removal of these 13 N-terminal amino acids reduced the proportion of NM39 and Saos-2 cells showing exclusively nucleolar staining (Figure 2) . The subcellular distribution of this ) was more dramatically altered in the NM39 cells than in Saos-2 cells; approximately half the transiently transfected NM39 cells showed cytoplasmic staining alone ( Figure  2 ) suggesting the deletion either aected nuclear import or enhanced its nuclear export in these cells.
To directly test the role of this ARF N-terminal domain in nucleolar import, p14ARF amino acids 1 ± 29 were fused to the EGFP reporter protein (p14ARF 1 ± 29 -EGFP) and the subcellular distribution of the fusion protein was determined. This construct did not express well in the NM39 cell line and its subcellular distribution could only be assessed in Saos-2. Relative to unfused EGFP, the 29 amino acid peptide from p14ARF signi®cantly increased the level of nucleolar association of EGFP in Saos-2 cells, demonstrating that this amino-terminal basic cluster is sucient for localizing a heterologous protein to the nucleolus ( Figure 3 ).
The critical residues within this conserved aminoterminal cluster were de®ned by site directed mutagenesis. Altering Arg-3 and Arg-4 residues to glycines (p14ARF To con®rm the importance of the 13 amino-terminal amino acids in p14ARF localization, the Arg-10 or the Arg-12 and Arg-13 residues were mutated in truncated constructs not carrying the previously reported (Zhang and Xiong, 1999) 
Characterization of the carboxy-terminal ARF nucleolar localization signal
We constructed a series of p14ARF deletion constructs to help de®ne an amino acid sequence in the Cterminus of the human ARF protein that was The shaded regions in p14ARF indicate the arginine rich nucleolar targeting domains identi®ed in this work. According to the relative intensity of¯uorescence in the cytoplasm, nucleoplasm and nucleolus of each individual cell, subcellular distributions of the FLAG-fusion proteins were divided into four groups, as indicated. The percentage of each localization was determined from a total of at least 400¯uorescent cells. The ability of each construct to arrest NM39 cells in the G 1 phase of the cell cycle is also indicated. a In addition to the described mutations (PRR to PAA) this construct encodes a silent amino acid change (Gly56Gly; GGG to GGT). nd, not determined; +/ 7, partial G 1 arrest relative to full-length p14ARF (see Figure  4b ) important for nucleolar import (data not shown). The sequence we de®ned overlapped with the C-terminal nucleolar localization domain recently identi®ed in p14ARF by Zhang and Xiong (1999) . To determine whether arginine residues within this C-terminal nucleolar localization domain were critical for localization we replaced Arg-81 and 82 (p14ARF PAA ) or ) with alanine residues. Both mutants showed reduced exclusively nucleolar staining and were distributed throughout the nucleus and cytoplasm of transfected NM39 and Saos-2 cells (Figure 2 ). The AAPA mutations were much more disruptive to p14ARF localization than the PAA mutations and the NM39 cells were more sensitive than Saos-2 to both changes (Figure 2 ).
The amino terminal nucleolar localization domain in p14ARF is important for cell cycle arrest and p14ARF-hdm2 binding
Immunostaining revealed nearly equivalent expression of wild-type p14ARF-FLAG and p14ARF 14 ± 132 -FLAG (lacking the N-terminal nucleolar localization domain) in total NM39 cell protein lysates (Figure 4a ). Nevertheless, p14ARF 14 ± 132 -FLAG consistently induced weak G 1 cell cycle arrest in this cell line (Figure 4b ). Similar results were observed in another p53+ melanoma cell line, NM177 (data not shown). The altered cellular localization of the p14ARF 14 ± 132 did not account for its reduced growth inhibitory activity. The subcellular distributions of the p14ARF 14 ± 132 and p14ARF 1 ± 64 proteins in NM39 cells were almost identical ( Figure  2 ), however p14ARF 1 ± 64 consistently induced a more potent growth arrest (Figure 4b ). To help de®ne the role of this amino-terminal domain on ARF induced cell cycle arrest we compared the ability of wild-type p14ARF, p14ARF 1 ± 64 , and p14ARF 14 ± 132 to bind hdm2 in vivo, using a mammalian two-hybrid assay system. Interestingly, p14ARF
1 ± 64 had a signi®cantly higher binding anity for hdm2 compared to the wild type ARF construct (Figure 4c ). This may be due to a change in ARF conformation which creates a more accessible hdm2 binding site, or to the co-localization of p14ARF 1 ± 64 and hdm2 in the nucleus. As shown in Figure 4c , the deletion of amino acids 1 ± 13 signi®cantly reduced the binding anity of p14ARF to hdm2. This result was con®rmed by immunoprecipitation (data not shown), and indicates that the Nterminal nucleolar localization domain of human p14ARF is required for nucleolar targeting and p14ARF-hdm2 binding.
Colocalization of hdm2, p53 and p14ARF
p14ARF has previously been shown to colocalize with hdm2 and p53 in discrete nuclear bodies (Zhang and Xiong, 1999) . We compared the ability of wild-type ARF and various ARF mutant constructs to form nuclear aggregates with p53 and hdm2. Endogenous hdm2 and p53 were detected by indirect immunouorescence in NM39 cells transiently expressing EGFP-tagged p14ARF constructs. To increase the levels of nuclear p53 and hdm2 (both of which shuttle between the nucleus and cytoplasm (Roth et al., 1998; Stommel et al., 1999) ), cells were treated with the nuclear export inhibitor, leptomycin B. This export inhibitor is widely used to inhibit the nuclear export of proteins and has been shown to induce the accumulation of both p53 and hdm2 in nuclear aggregates (Lain et al., 1999) . Nevertheless, although low p53 levels necessitated the use of leptomycin B for these experiments, treatment with this drug may produce unknown side eects. As a result several controls, including transfection with the green¯uor- Figure 4 The p14ARF amino-terminal nucleolar localization domain is important for cell cycle inhibition and hdm2 binding. (a) Lysates were prepared from NM39 cells 40 h after transfecting with the indicated FLAG plasmids and the pEGFPN1 vector. Protein expression was analysed by sequential immunostaining with anti-FLAG and anti-EGFP antibodies. The arrows indicate the positions of the wild-type and mutant p14ARF proteins. (b) NM39 melanoma cells were transfected with the indicated ARF-FLAG plasmid and pCMVEGFP-spectrin. The cell cycle distribution of green¯uorescent cells was determined, 40 h post transfection, using propidium iodide staining. The G 1 -phase arrest induced by wild-type p14ARF was set at 100% and the arrest induced by the ARF mutants was expressed relative to the wildtype protein. Each result is derived from at least three independent transfection experiments. The percentage data from one such experiment are: FLAG vector (G1 : 73.9%, S : 13.3%, G2 : 12.8%); p14ARF-FLAG (G1 : 95.4%, S : 1.7%, G2 : 2.9%); p14ARF 1 ± 64 -FLAG (G1 : 94.4%, S : 1.2%, G2 : 4.4%); p14ARF 14 ± 132 (G1 : 85.3%, S : 4.9%, G2 : 9.8%); (c) ARF-hDM2 binding anity was determined using the two-hybrid assay system in Saos-2 cells. Two independent transfection experiments were each performed in triplicate for each ARF construct escent protein (EGFP), were included in these experiments.
Without leptomycin B treatment, p53 was undetectable and hdm2 was distributed evenly throughout the nucleus of NM39 cells (data not shown). After a 16 h exposure to leptomycin B, cells were ®xed and immunostained for hdm2 or p53. As shown in Figure  5 , EGFP showed even nuclear-cytoplasmic staining that did not speci®cally overlap with either hdm2 or p53 staining; however both p53 and hdm2 were concentrated in discrete nuclear bodies, separate from the nucleoli, after leptomycin B treatment. The EGFPtagged exon2-encoded p14ARF domain (p14ARF 65 ± 132 ) which does not bind hdm2, did not colocalize with either hdm2 or p53 ( Figure 5 ). In contrast, wild-type p14ARF and the exon1b-encoded domain (p14ARF 1 ± 64 ) displayed punctate patterns that overlapped the p53 and hdm2 staining nuclear punctate dots, con®rming previous data that ARF, hdm2 and p53 colocalize in nuclear bodies (Zhang and Xiong, 1999) . The EGFP tagged p14ARF 14 ± 132 construct (lacking the aminoterminal nucleolar localization domain) accumulated in the nucleus and cytoplasm with some co-staining, in nuclear bodies, with hdm2 and p53. The accumulation of p14ARF 14 ± 132 in nuclear bodies, that co-stained with either hdm2 or p53, was consistently less intense than for the wild-type ARF and p14ARF -EGFP protein remained in the nucleoplasm, thus con®rming that the aminoterminal p14ARF domain is important for nucleolar localization and hdm2 binding.
Nuclear accumulation of p14ARF is necessary for cell cycle inhibition
The p14ARF 1 ± 64 -FLAG and p14ARF 14 ± 132 -FLAG constructs were excluded from the nucleus in approximately 50% of transfected NM39 cells (see Figure 2) . To determine whether cell growth was inhibited in cells expressing`cytoplasmic only' p14ARF we assessed cell proliferation in transiently transfected NM39 cells, using the Ki67 antigen as a proliferation marker. The Ki67 antibody reacts with a nuclear proliferationassociated antigen that accumulates to high levels in proliferating cells during late G1, S, M, and G2 phases of the cell cycle (Cattoretti et al., 1992) . NM39 cells transfected with various p14ARF-FLAG constructs were immunostained for the FLAG and Ki67 antigens, 40 h post transfection. Actively proliferating cells showed strong nucleolar staining with the Ki67 antibody (data not shown). As expected, only 6% of NM39 cells expressing wild-type p14ARF-FLAG were proliferating, whereas 49% of NM39 cells with p14ARF 65 ± 132 -FLAG expression were in the active phases of the cell cycle ( Figure 6 ). This supports thē ow cytometric data, indicating that p14ARF, but not p14ARF 65 ± 132 , induces G1 growth arrest in NM39 cells (see Figure 1) . Surprisingly, 20% of NM39 cells expressing the potent cell cycle inhibitor, p14ARF -FLAG construct; 17% of cells with nuclear ARF 14 ± 132 were cycling whereas 43% of cells with`cytoplasmic only' p14ARF 14 ± 132 were proliferating ( Figure 6 ). The relatively high percentage of proliferating cells with nuclear p14ARF 14 ± 132 , is presumably due to the reduced hdm2 binding anity of this construct (see Figure 4) . This data indicate that nuclear accumulation of ARF is important for its cell cycle inhibitory activity. We were unable to determine whether nucleolar accumulation of ARF is required for growth arrest, because only a small proportion of transfected NM39 cells accumulated nuclear p14ARF that was excluded from the nucleolus.
Discussion
The human and murine ARF proteins are highly divergent, sharing only 50% amino acid homology overall . Nevertheless, both proteins stabilize p53 by binding h/mdm2 and inhibiting the in vitro ubiquitin ligation (Honda and Yasuda, 1999) or nuclear export of p53 by h/ mdm2 (Zhang et al., 1998) . These proteins dier in the ®ne details of their function; murine p19ARF binds mdm2 and is retained in the nucleolus with mdm2, but not p53 (Weber et al., 1999) whereas the interaction between hdm2 and human p14ARF relocates nucleolar p14ARF into discrete nuclear bodies with hdm2 and p53 (Zhang et al., 1998) . It is not surprising therefore, that the signals targeting human and murine ARF proteins to the cell nucleoli dier. The exon1b-encoded motif (residues 26 ± 37) of mouse ARF is sucient to mediate nucleolar localization (Weber et al., 1999) . In contrast, we have shown that two basic amino acid domains, in the amino-and carboxy-termini of human p14ARF are necessary for the correct localization of this protein. The p14ARF carboxy terminal nucleolar localization domain identi®ed by Zhang and Xiong (1999) overlaps with the domain reported in this study (see Table 1 ).
Unlike the p14ARF C-terminal nucleolar-targeting domain, the N-terminal motif we identi®ed is highly conserved between the human, mouse and Monodelphis ARF proteins (Figure 2) , suggesting functional importance. We have shown that deletion of this 13 amino acid cluster impairs nucleolar localization, diminishes the cell cycle inhibitory activity of human ARF and reduces its hdm2 binding activity. The Arg-12 and -13 amino acids are important for nucleolar localization but not cell cycle inhibition. Mutants at the highly conserved Arg-3, Arg-4, Val-7 and Thr-8 did not express well and the eects of these on the cell cycle could not be analysed. We were able to verify that altering the Arg-3 and Arg-4 residues to glycine residues (p14ARF GG ) did not alter the subcellular distribution of p14ARF (Figure 2) .
Although amino acid residues 1 ± 13 have not been directly analysed in the mouse ARF protein, their functional importance can be inferred. It is known that residues 1 ± 62 are required for p19ARF-mdm2 binding and that mouse ARF carrying a deletion of residues 26 ± 37 or 38 ± 52 was still able to bind mdm2 (Weber et al., 1999) . Consequently, residues 1 ± 25 and/or 53 ± 62 must be involved in the binding of mdm2 to p19ARF, and the 13 amino terminal residues of p19ARF share almost 70% homology with the human and Monodelphis ARF proteins.
It is possible that the overlap of nucleolar localization and hdm2 binding domains in the amino-terminus of human ARF results in competition between hdm2-ARF binding and ARF nucleolar tethering. This may explain why hdm2-p14ARF binary complexes are not sequestered in the nucleoli of human cells, but are free to bind p53 in the nucleoplasm (Zhang and Xiong, 1999) . This is dierent to the situation in mouse cells; p19ARF sequesters mdm2 in the nucleoli (possibly because the mdm2 and nucleolar targeting domains do not overlap), leaving mouse p53 free in the nucleoplasm (Weber et al., 1999) . It is clear from our data that the nuclear accumulation of p14ARF is necessary for cell cycle arrest and it will be interesting to determine whether the nucleolar targeting of this protein is also required for this function.
The C-terminal p14ARF nucleolar localization domain, while not required for hdm2 binding, is essential for full ARF activity. Mutations in this domain have been previously shown to reduce the ability of ARF to stabilize p53 (Zhang et al., 1998) . A search through known CDKN2A exon2-mutations revealed that the Cterminal nucleolar import domain sequence was altered in several melanoma prone kindreds (Holland et al., 1999; Sou®r et al., 1998) , sporadic dysplastic naevi (Lee et al., 1997) and in primary sporadic melanomas (Piccinin et al., 1997) . Most of these mutations alter the sequence of both p14ARF and p16
INK4a
, and although their eect on p16
INK4a function has not been investigated, these mutations lie within loop2, a conserved but exible domain, which connects ankyrin repeats II and III (Byeon et al., 1998) . For instance, the p16 INK4a mutations Gly67Ser and Ala68Leu correspond to the p14ARF alterations Arg81Gln and Arg82Leu and have been found to segregate with melanoma in an Australian and Italian melanoma-prone kindred, respectively (Holland et al., 1999; Sou®r et al., 1998) . The eect of these mutations on the cellular distribution and function p14ARF and p16
INK4a is currently under investigation. In one primary melanoma, a silent amino acid change in p16 INK4a (Ala73Ala) (Piccinin et al., 1997) would prematurely terminate p14ARF, essentially truncating the C-terminal nucleolar-targeting domain (Arg-88 and -90 are not translated). The eect of such mutations can only be determined once the role of p14ARF in the nucleolus is better understood.
The identi®cation of the domains targeting p14ARF to the nucleolus may provide some clues regarding nucleolar p14ARF function. Speci®cally, the domains identi®ed in this work are similar to the arginine rich RNA binding domains of other nucleolar proteins, including the human immunode®ciency virus regulatory proteins, Rev and Tat (Burd and Dreyfuss, 1994) . In these viral proteins, the basic sequences interact with importin b (a nuclear import factor) (Henderson and Percipalle, 1997) and several RNA species. The possible interaction between p14ARF and similar partners suggests that, like hdm2 and p53, p14ARF may be a multifunctional protein participating in several aspects of the controlled growth and ageing of cells.
Materials and methods
Plasmid constructs
p14ARF cDNA was synthesized using RT ± PCR and p14ARF speci®c primers from total RNA extracted from a lymphoblastoid cell line, as previously described (Rizos et al., 1997) . ARF deletion and point mutants were engineered by PCR-mediated mutagenesis. All mutants were ligated to the N-terminus of the FLAG-epitope encoded by the pFLAG-CMV-5b vector (Sigma) and completely sequenced. Several ARF mutants were also cloned in frame with the green¯uorescent protein in the pEGFPN1 vector (Clontech).
Cell culture and transfections NM39, a human melanoma cell line, expresses pRb and p53. This cell line carries wild-type CDKN2A and exon 1b sequences but does not express detectable p16
INK4a or p14ARF as determined by RT ± PCR (Rizos et al., 1999) . NM39 and Saos-2 cells were grown in Dulbecco's modi®ed Eagle's medium (Trace Scienti®c, Sydney) supplemented with 10% foetal bovine serum and glutamine. Leptomycin B was premixed in culture media (4 ng/ml), added approximately 30 h post transfection and cells were treated for 16 h.
For immuno¯uorescence studies, cultured cells (1610 5 ) were seeded on coverslips in six-well plates and transfected with 1 ± 3 mg puri®ed plasmid using calcium phosphate precipitation method. For cell cycle distribution analysis, cultured cells (3610 5 ) were seeded in T25¯asks and cotransfected with the pFLAG-CMV-5b expression plasmid (3 mg) and pCMVEGFP-spectrin (1 mg).
Indirect immunofluorescence
Approximately 40 h after transfection, cells were washed in PBS and ®xed in 3.7% formaldehyde. Cells were immunostained for 50 min with either monoclonal mouse anti-FLAG M2 antibody (Sigma), mouse anti-mdm2 (Pharmingen), mouse anti-p53 (Santa Cruz) or rabbit Ki67 (Novacastra) followed by a 50 min exposure to either a FITC-or texas red-conjugated anti-mouse or rabbit secondary IgG (Roche, Molecular Probes). Dual immunostaining for the FLAG and Ki67 antigens was carried out by sequential immuno¯uores-cence. The mouse anti-FLAG M2 antibody was detected with the FITC conjugated anti-mouse IgG and this was followed by incubation with the Ki67 antibody and the texas red conjugated anti-rabbit IgG. Nuclei were visualized by Hoechst 33258 staining (2 mg/ml). Subcellular distribution was determined from a total of 400 ± 600¯uorescent cells, unless otherwise indicated.
Cell cycle analysis of transfected NM39 cells
Forty hours post transfection, cells were ®xed in 80% ethanol at 48C for at least 1 h, washed in PBS and stained with propidium iodide (50 ng/ml) containing ribonuclease A (50 ng/ml). EGFP-spectrin was used as a marker for analysis of transfected cells. DNA content from at least 2000 EGFPspectrin positive cells was analysed using the FACScan Cell Fit software.
Western blotting
Total cell protein was extracted using a PBS buer containing 1% NP-40, 0.1% SDS and protease inhibitors (Roche). Electrophoresis was performed on SDS-polyacrylamide gels and proteins were transferred to nitrocellulose membranes (Amersham). Western immunoblotting of p14ARF-FLAG was carried out using the monoclonal mouse anti-FLAG M2 antibody and detection of EGFP proteins was performed using a commercial polyclonal EGFP antibody (Clontech).
Mammalian two-hybrid assay
Wild-type p14ARF, p14ARF 1 ± 64 , p14ARF
14 ± 132 were each cloned in frame with the GAL4 nuclear localization signal in the pM vector (Clontech). The hDM2 cDNA was digested out of the pCMV-hdm2 plasmid and cloned in frame with the SV40 nuclear localization sequence in the pVP16 vector (Clontech). Each assay was performed in triplicate using Saos-2 cells seeded in 6-well plates (1.5610 5 cells/well). Each well was transfected with a total of 4 mg DNA consisting of the pM DNA, hDM2-pVP16, the pG51uc reporter vector (Promega) and pEGFPN1 vector (Clontech) in a 5 : 5 : 1 : 1 mg ratio. Cells were assayed 40 h post transfection essentially as described by the manufacturer. Transfection eciencies were determined by quantitating the number of green¯uorescent cells using a Coulter EPICS Pro®le II¯ow cytometer.
